Showing results (131-140 of 185) with videos related to

Sort By:
Pageof 19
Frontiers in Oncology|June 14, 2021
Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian SubstudyLidia Borghi, Gianantonio Rosti, Alessandro Maggi, et al.
Leukemia Research|December 10, 2013
Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profileFrancesca R Mauro, Stefano Molica, Luca Laurenti, et al.
British Journal of Haematology|April 4, 2018
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristicsGian Matteo Rigolin, Elena Saccenti, Emanuele Guardalben, et al.
Hematological Oncology|February 16, 2021
Impact of comorbidities and body mass index on the outcome of polycythemia vera patientsGiulia Benevolo, Elena M Elli, Daniela Bartoletti, et al.
Hematological Oncology|April 16, 2019
Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinibFrancesca Palandri, Giuseppe A Palumbo, Elisabetta Abruzzese, et al.
Hematological Oncology|March 19, 2021
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working GroupGian Matteo Rigolin, Francesco Cavazzini, Alfonso Piciocchi, et al.
Cancers|August 12, 2022
<i>TP53</i> Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex KaryotypeSilvia Ramos-Campoy, Anna Puiggros, Joanna Kamaso, et al.
Cancers|June 29, 2019
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12Francesco Autore, Paolo Strati, Idanna Innocenti, et al.
Hematological Oncology|July 1, 2023
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia studyFrancesco Autore, Idanna Innocenti, Gianluigi Reda, et al.
Blood|March 2, 2021
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugsCandida Vitale, Chiara Salvetti, Valentina Griggio, et al.
Pageof 19